Abnormal lipid metabolism has been identified as a potential pathogenic mechanism of Alzheimer's disease (AD), which might be epigenetically regulated. Lysosomes are critical organelles for lipid metabolism. However, the epigenetic modifications of lysosome and lipid regulating genes remain unclear in AD patients.
Objective
Explore the role of abnormal epigenetic modifications, especially methylation of lysosome and lipid metabolism-related genes in AD.
Methods
Methylation beadchip and MALDI-TOF mass spectrometry were used to detect genome-wide DNA methylation levels and validate key gene methylation, respectively. Clinical data were collected from all participants. Associations between clinical biochemical characteristics and altered DNA methylation in AD patients were analyzed, and a risk factor model of AD was established.
Results
41 differentially methylated positions (DMPs) corresponding to 33 genes were identified in AD patients, with 18 hypermethylated and 23 hypomethylated positions. Significant alterations were observed in lipid regulating genes (CTNNB1, DGKQ, SLC27A1) and lysosomal transmembrane gene (TMEM175). Clinical analysis revealed that TP, ALB, IB, ADA, ALP, HCY, GLU, TC, BUN, HDL-C, LDL-C, and APOA1 levels were significantly higher in AD patients, whereas A/G and DB levels were lower. TMEM175 hypermethylation was further verified and found to correlate with TC, HDL-C, LDL-C, APOA1, IB, and HCY. The AUC of the AD risk model, which integrated clinical lipid markers and TMEM175 methylation, reached 0.9519 (p < 0.0001).
Conclusions
Abnormal epigenetic regulation of lysosomal gene and lipid dyshomeostasis were high-risk factors in AD. Methylation modifications of lysosome and lipid regulating genes might be key processes in AD pathogenesis.
RenGSongSZhangS-X, et al.Brain region-specific genome-wide deoxyribonucleic acid methylation analysis in patients with Alzheimer’s disease. Front Mol Neurosci2023; 16: 971565.
2.
ZhangJZhangYWangJ, et al.Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther2024; 9: 211.
3.
ReitzCPericak-VanceMAForoudT, et al.A global view of the genetic basis of Alzheimer disease. Nat Rev Neurol2023; 19: 261–277.
4.
BryzgalovLOKorbolinaEEMerkulovaTI. Exploring the genetic predisposition to epigenetic changes in Alzheimer’s disease. Int J Mol Sci2023; 24: 7955.
HuJZhuHXuG, et al.Significant association between DHFR promoter methylation and ischemic stroke in a Chinese hypertensive population. Clin Lab Anal2020; 34: e23322.
7.
WuY-LLinZ-JLiC-C, et al.Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Sig Transduct Target Ther2023; 8: 98.
8.
VillaCCombiR. Epigenetics in Alzheimer’s disease: a critical overview. Int J Mol Sci2024; 25: 5970.
9.
De PlanoLMSaittaAOddoS, et al.Epigenetic changes in Alzheimer’s disease: DNA methylation and histone modification. Cells2024; 13: 719.
10.
YinF. Lipid metabolism and Alzheimer’s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J2023; 290: 1420–1453.
11.
LiuC-CWangNChenY, et al.Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer’s disease. Nat Immunol2023; 24: 1854–1866.
12.
LoikaYLoikoEFengF, et al.Exogenous exposures shape genetic predisposition to lipids, Alzheimer’s, and coronary heart disease in the MLXIPL gene locus. Aging2023; 15: 3249–3272.
13.
LiuSLiYWeiX, et al.Genetic analysis of DNA methylation in dyslipidemia: a case-control study. PeerJ2022; 10: e14590.
14.
Gomez-AlonsoMDCKretschmerAWilsonR, et al.DNA Methylation and lipid metabolism: an EWAS of 226 metabolic measures. Clin Epigenet2021; 13: 7.
15.
KaurGPawlikMGandySE, et al.Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein. Mol Psychiatry2017; 22: 981–989.
16.
WhyteLSLauAAHemsleyKM, et al.Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer’s disease?J Neurochem2017; 140: 703–717.
17.
FernandezMABahFMaL, et al.Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons. Stem Cell Rep2022; 17: 2111–2126.
18.
LeeJ-HYangD-SGoulbourneCN, et al.Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat Neurosci2022; 25: 688–701.
19.
EmburyCMDyavarshettyBLuY, et al.Cathepsin B improves β-amyloidosis and learning and memory in models of Alzheimer’s disease. J Neuroimmune Pharmacol2017; 12: 340–352.
20.
AvrahamiLFarfaraDShaham-KolM, et al.Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model. J Biol Chem2013; 288: 1295–1306.
21.
TorresMJimenezSSanchez-VaroR, et al.Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus. Mol Neurodegener2012; 7: 59.
22.
NieJJiangL-SZhangY, et al.Dendrobium nobile Lindl. alkaloids decreases the level of intracellular β-amyloid by improving impaired autolysosomal proteolysis in APP/PS1 mice. Front Pharmacol2018; 9: 1479.
23.
MenonDBhapkarAManchandiaB, et al.ARL8B Mediates lipid droplet contact and delivery to lysosomes for lipid remobilization. Cell Rep2023; 42: 113203.
24.
SettembreCPereraRM. Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat Rev Mol Cell Biol2024; 25: 223–245.
25.
HaHTTLiuSNguyenXTA, et al.Lack of SPNS1 results in accumulation of lysolipids and lysosomal storage disease in mouse models. JCI Insight2024; 9: e175462.
26.
BaharudinRIshakMMuhamad YusofA, et al.Epigenome-wide DNA methylation profiling in colorectal cancer and normal adjacent colon using infinium human methylation 450K. Diagnostics2022; 12: 198.
27.
AryeeMJJaffeAECorrada-BravoH, et al.Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics2014; 30: 1363–1369.
28.
AlhassanDOlbrichtGRAdekpedjouA. Differential methylation region detection via an array-adaptive normalized kernel-weighted model. PLoS One2024; 19: e0306036.
29.
SmythGK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol2004; 3: 3.
30.
WuCRuanTYuanY, et al.Alterations in synaptic connectivity and synaptic transmission in Alzheimer’s disease with high physical activity. J Alzheimers Dis2024; 99: 1005–1022.
KanehisaMGotoS. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res2000; 28: 27–30.
33.
DonchevaNTMorrisJHGorodkinJ, et al.Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res2019; 18: 623–632.
34.
Hajian-TilakiK. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med2013; 4: 627–635.
35.
AltuzarJNotbohmJSteinF, et al.Lysosome-targeted multifunctional lipid probes reveal the sterol transporter NPC1 as a sphingosine interactor. Proc Natl Acad Sci U S A2023; 120: e2213886120.
36.
HuMLiPWangC, et al.Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell2022; 185: 2292–2308.
37.
ZhangZ-HCaoX-CPengJ-Y, et al.Reversal of lipid metabolism dysregulation by selenium and folic acid co-supplementation to mitigate pathology in Alzheimer’s disease. Antioxidants2022; 11: 829.
38.
ZangFLiuXFanD, et al.Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer’s disease. CNS Neurosci Ther2024; 30: e70029.
39.
HaneyMSPálovicsRMunsonCN, et al.APOE4/4 Is linked to damaging lipid droplets in Alzheimer’s disease microglia. Nature2024; 628: 154–161.
40.
ShiJXuJChenYE, et al.The concurrence of DNA methylation and demethylation is associated with transcription regulation. Nat Commun2021; 12: 5285.
41.
SchübelerD. Function and information content of DNA methylation. Nature2015; 517: 321–326.
42.
TabelliniGBortulRSantiS, et al.Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus. Exp Cell Res2003; 287: 143–154.
43.
GuX-JSuW-MDouM, et al.Expanding causal genes for Parkinson’s disease via multi-omics analysis. NPJ Parkinsons Dis2023; 9: 146.
44.
IshisakaMHaraH. The roles of diacylglycerol kinases in the central nervous system: review of genetic studies in mice. J Pharmacol Sci2014; 124: 336–343.
45.
WuDWangJChangY, et al.Rutaecarpin reduces lipids by DGKθ-dependent activation of PPARα. Obesity2022; 30: 2424–2439.
46.
LeMUTParkJHSonJG, et al.Monitoring lipid alterations in Drosophila heads in an amyotrophic lateral sclerosis model with time-of-flight secondary ion mass spectrometry. Analyst2024; 149: 846–858.
47.
ZhaoJIkezuTCLuW, et al.APOE Deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids. Stem Cell Res Ther2023; 14: 214.
48.
ThelenAMZoncuR. Emerging roles for the lysosome in lipid metabolism. Trends Cell Biol2017; 27: 833–850.
DingEDengFFangJ, et al.Exposome-wide ranking to uncover environmental chemicals associated with dyslipidemia: a panel study in healthy older Chinese adults from the BAPE study. Environ Health Perspect2024; 132: 097005.
57.
Juul RasmussenILuoJFrikke-SchmidtR. Lipids, lipoproteins, and apolipoproteins: associations with cognition and dementia. Atherosclerosis2024; 398: 118614.
58.
HuangHYangBYuR, et al.Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults. Nutr J2024; 23: 79.
59.
PillaiJABenaJBekrisL, et al.Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease. Alzheimers Res Ther2023; 15: 54.
60.
AnsellBJNavabMHamaS, et al.Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation2003; 108: 2751–2756.
61.
RosensonRSBrewerHBAnsellBJ, et al.Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol2016; 13: 48–60.
62.
CepriánNMartínez De TodaIMatéI, et al.Prodromic inflammatory–oxidative stress in peritoneal leukocytes of triple-transgenic mice for Alzheimer’s disease. Int J Mol Sci2024; 25: 6976.
63.
HuiLChenXGeigerJD. Endolysosome involvement in LDL cholesterol-induced Alzheimer’s disease-like pathology in primary cultured neurons. Life Sci2012; 91: 1159–1168.
64.
SchillingSTzourioCSoumaréA, et al.Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study. PLoS Med2017; 14: e1002265.
65.
BaiXQiaoJZhangH. Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups. Lipids Health Dis2023; 22: 213.
66.
ZhongXLiaoYChenX, et al.Abnormal serum bilirubin/albumin concentrations in dementia patients with Aβ deposition and the benefit of intravenous albumin infusion for Alzheimer’s disease treatment. Front Neurosci2020; 14: 859.
67.
PiTLiuBShiJ. Abnormal homocysteine metabolism: an insight of Alzheimer’s disease from DNA methylation. Behav Neurol2020; 2020: 8438602.
68.
JinPGaoDCongG, et al.Role of PCSK9 in homocysteine-accelerated lipid accumulation in macrophages and atherosclerosis in ApoE−/− mice. Front Cardiovasc Med2021; 8: 746989.
69.
JinPBianYWangK, et al.Homocysteine accelerates atherosclerosis via inhibiting LXRα–mediated ABCA1/ABCG1–dependent cholesterol efflux from macrophages. Life Sci2018; 214: 41–50.
70.
SodaK. Polyamine metabolism and gene methylation in conjunction with one-carbon metabolism. Int J Mol Sci2018; 19: 3106.
71.
KunkleBWGrenier-BoleyBSimsR, et al.Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet2019; 51: 414–430.
72.
PraIChiariniAPacchianaR, et al.Calcium-sensing receptors of human astrocyte-neuron teams: amyloid-β-driven mediators and therapeutic targets of Alzheimer’s disease. Curr Neuropharmacol2014; 12: 353–364.
73.
FengCBaoXShanL, et al.Calcium-sensing receptor mediates β-amyloid-induced synaptic formation impairment and cognitive deficits via regulation of cytosolic phospholipase A2/prostaglandin E2 metabolic pathway. Front Aging Neurosci2020; 12: 144.
74.
ChewHSolomonVAFontehAN. Involvement of lipids in Alzheimer’s disease pathology and potential therapies. Front Physiol2020; 11: 598.
75.
ZhaoLZhouQHeL, et al.DNA Methylation underpins the epigenomic landscape regulating genome transcription in Arabidopsis. Genome Biol2022; 23: 197–217.
76.
SmithARSmithRGMacdonaldR, et al.The histone modification H3K4me3 is altered at the ANK1 locus in Alzheimer’s disease brain. Future Sci OA2021; 7: FSO665.
77.
BehlTKyadaARoopashreeR, et al.Epigenetic biomarkers in Alzheimer’s disease: diagnostic and prognostic relevance. Ageing Res Rev2024; 102: 102556.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
